These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18407534)

  • 21. Anti-neutrophilic inflammatory activity of ASP3258, a novel phosphodiesterase type 4 inhibitor.
    Kubo S; Kobayashi M; Iwata M; Miyata K; Takahashi K; Shimizu Y
    Int Immunopharmacol; 2012 Jan; 12(1):59-63. PubMed ID: 22041526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and characterisation of a novel and rapid lung eosinophil influx model in the rat.
    Werner-Klein M; Göggel R; Westhof A; Erb KJ
    Pulm Pharmacol Ther; 2008 Aug; 21(4):648-56. PubMed ID: 18490184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The preclinical pharmacology of roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease.
    Hatzelmann A; Morcillo EJ; Lungarella G; Adnot S; Sanjar S; Beume R; Schudt C; Tenor H
    Pulm Pharmacol Ther; 2010 Aug; 23(4):235-56. PubMed ID: 20381629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cigarette smoke differentially affects eosinophilia and remodeling in a model of house dust mite asthma.
    Botelho FM; Llop-Guevara A; Trimble NJ; Nikota JK; Bauer CM; Lambert KN; Kianpour S; Jordana M; Stämpfli MR
    Am J Respir Cell Mol Biol; 2011 Oct; 45(4):753-60. PubMed ID: 21317378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling.
    Johnson JR; Wiley RE; Fattouh R; Swirski FK; Gajewska BU; Coyle AJ; Gutierrez-Ramos JC; Ellis R; Inman MD; Jordana M
    Am J Respir Crit Care Med; 2004 Feb; 169(3):378-85. PubMed ID: 14597485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of the oral thrombin inhibitor dabigatran on allergic lung inflammation induced by repeated house dust mite administration in mice.
    de Boer JD; Berkhout LC; de Stoppelaar SF; Yang J; Ottenhoff R; Meijers JC; Roelofs JJ; van't Veer C; van der Poll T
    Am J Physiol Lung Cell Mol Physiol; 2015 Oct; 309(8):L768-75. PubMed ID: 26320153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short cigarette smoke exposure facilitates sensitisation and asthma development in mice.
    Lanckacker EA; Tournoy KG; Hammad H; Holtappels G; Lambrecht BN; Joos GF; Maes T
    Eur Respir J; 2013 May; 41(5):1189-99. PubMed ID: 22903968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tiotropium bromide inhibits relapsing allergic asthma in BALB/c mice.
    Bosnjak B; Tilp C; Tomsic C; Dekan G; Pieper MP; Erb KJ; Epstein MM
    Pulm Pharmacol Ther; 2014 Feb; 27(1):44-51. PubMed ID: 24090641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Corticosteroid treatment inhibits airway hyperresponsiveness and lung injury in a murine model of chemical-induced airway inflammation.
    Wigenstam E; Jonasson S; Koch B; Bucht A
    Toxicology; 2012 Nov; 301(1-3):66-71. PubMed ID: 22776411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in respiratory syncytial virus and influenza infection in a house-dust-mite-induced asthma mouse model: consequences for steroid sensitivity.
    Mori H; Parker NS; Rodrigues D; Hulland K; Chappell D; Hincks JS; Bright H; Evans SM; Lamb DJ
    Clin Sci (Lond); 2013 Dec; 125(12):565-74. PubMed ID: 23789621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation.
    Ullah MA; Loh Z; Gan WJ; Zhang V; Yang H; Li JH; Yamamoto Y; Schmidt AM; Armour CL; Hughes JM; Phipps S; Sukkar MB
    J Allergy Clin Immunol; 2014 Aug; 134(2):440-50. PubMed ID: 24506934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transforming growth factor-beta regulates house dust mite-induced allergic airway inflammation but not airway remodeling.
    Fattouh R; Midence NG; Arias K; Johnson JR; Walker TD; Goncharova S; Souza KP; Gregory RC; Lonning S; Gauldie J; Jordana M
    Am J Respir Crit Care Med; 2008 Mar; 177(6):593-603. PubMed ID: 18174546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of volatile constituents of a rosemary extract on allergic airway inflammation related to house dust mite allergen in mice.
    Inoue K; Takano H; Shiga A; Fujita Y; Makino H; Yanagisawa R; Ichinose T; Kato Y; Yamada T; Yoshikawa T
    Int J Mol Med; 2005 Aug; 16(2):315-9. PubMed ID: 16012768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dectin-2 promotes house dust mite-induced T helper type 2 and type 17 cell differentiation and allergic airway inflammation in mice.
    Norimoto A; Hirose K; Iwata A; Tamachi T; Yokota M; Takahashi K; Saijo S; Iwakura Y; Nakajima H
    Am J Respir Cell Mol Biol; 2014 Aug; 51(2):201-9. PubMed ID: 24588637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nerve growth factor derived from bronchial epithelium after chronic mite antigen exposure contributes to airway hyperresponsiveness by inducing hyperinnervation, and is inhibited by in vivo siRNA.
    Ogawa H; Azuma M; Uehara H; Takahashi T; Nishioka Y; Sone S; Izumi K
    Clin Exp Allergy; 2012 Mar; 42(3):460-70. PubMed ID: 22168511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dehydroxymethylepoxyquinomicin (DHMEQ), a novel NF-kappaB inhibitor, inhibits allergic inflammation and airway remodelling in murine models of asthma.
    Shimizu K; Konno S; Ozaki M; Umezawa K; Yamashita K; Todo S; Nishimura M
    Clin Exp Allergy; 2012 Aug; 42(8):1273-81. PubMed ID: 22805475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-administration of vaccination with DNA encoding T cell epitope on the Der p and BCG inhibited airway remodeling in a murine model of chronic asthma.
    Kim CH; Ahn JH; Kim SJ; Lee SY; Kim YK; Kim KH; Moon HS; Song JS; Park SH; Kwon SS
    J Asthma; 2006; 43(5):345-53. PubMed ID: 16801138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitors.
    Wollin L; Bundschuh DS; Wohlsen A; Marx D; Beume R
    Pulm Pharmacol Ther; 2006; 19(5):343-52. PubMed ID: 16257550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repeated instillations of Dermatophagoides farinae into the airways can induce Th2-dependent airway hyperresponsiveness, eosinophilia and remodeling in mice: effect of intratracheal treatment of fluticasone propionate.
    Wakahara K; Tanaka H; Takahashi G; Tamari M; Nasu R; Toyohara T; Takano H; Saito S; Inagaki N; Shimokata K; Nagai H
    Eur J Pharmacol; 2008 Jan; 578(1):87-96. PubMed ID: 17915213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of the phosphodiesterase type 4 inhibitor roflumilast on early and late allergic response and airway hyperresponsiveness in Aspergillus-fumigatus-sensitized mice.
    Hoymann HG; Wollin L; Muller M; Korolewitz R; Krug N; Braun A; Beume R
    Pharmacology; 2009; 83(3):188-95. PubMed ID: 19176983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.